Capricor Therapeutics (CAPR) FCF Margin (QoQ) (2011 - 2024)

Capricor Therapeutics (CAPR) FCF Margin (QoQ) (2011 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Capricor Therapeutics 457.86 Mn 457.86 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 37,786.00
Sep 30, 2024 -20,424.00
Jun 30, 2024 -29,217.00
Mar 31, 2024 8,176.00
Dec 31, 2023 4,600.00
Sep 30, 2023 9,734.00
Jun 30, 2023 -37,319.00
Mar 31, 2023 92,066.00
Dec 31, 2022 -39,907.00
Jun 30, 2021 587,738.00
Mar 31, 2021 -110,494.00
Dec 31, 2020 1.14 Mn
Sep 30, 2020 -1.43 Mn
Jun 30, 2020 -360,387.00
Mar 31, 2020 14,770.00
Dec 31, 2019 35,865.00
Sep 30, 2019 -72,922.00
Jun 30, 2019 26,433.00
Mar 31, 2019 -11,797.00
Dec 31, 2018 84,694.00